Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02334722 : 1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients
PhaseN/A
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- Adult (>18 years of age and older) patients who have or will have undergone surgical
resection or biopsy of a supratentorial brain tumor and are able to consent for
themselves.

- Able to be randomized prior to or up to 48 hours after surgery.

Exclusion Criteria:

- No known history of seizure activity.

- Pregnant or breastfeeding.

- Renal dysfunction (CrCl < 30ml/min).

- Beck's Depression Inventory (BDI) ?14

- Allergy to levetiracetam.
LinksPermanent Link to THIS page: http://virtualtrials.com/nct/display1trial.cfm?nct=NCT02334722      |      Link to official Clinicaltrials.gov listing
Locations
Gainesville, Florida
Facility: University of Florida
Investigator: Maryam Rahman, MS, MD
Contact: Jessica Smith, RN Phone: 352-273-7773
Click HERE to send email to this center




Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites